Comprehensive ex vivo transposon mutagenesis identifies genes that promote growth factor independence and leukemogenesis

Yabin Guo, Barrett L. Updegraff, Sunho Park, Deniz Durakoglugil, Victoria H. Cruz, Sarah Maddux, Tae Hyun Hwang, Kathryn A O'Donnell-Mendell

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aberrant signaling through cytokine receptors and their downstream signaling pathways is a major oncogenic mechanism underlying hematopoietic malignancies. To better understand how these pathways become pathologically activated and to potentially identify new drivers of hematopoietic cancers, we developed a high-throughput functional screening approach using ex vivo mutagenesis with the Sleeping Beauty transposon. We analyzed over 1,100 transposon-mutagenized pools of Ba/F3 cells, an IL3-dependent pro-B-cell line, which acquired cytokine independence and tumor-forming ability. Recurrent transposon insertions could be mapped to genes in the JAK/ STAT and MAPK pathways, confirming the ability of this strategy to identify known oncogenic components of cytokine signaling pathways. In addition, recurrent insertions were identified in a large set of genes that have been found to be mutated in leukemia or associated with survival, but were not previously linked to the JAK/STAT or MAPK pathways nor shown to functionally contribute to leukemogenesis. Forced expression of these novel genes resulted in IL3-independent growth in vitro and tumorigenesis in vivo, validating this mutagenesis-based approach for identifying new genes that promote cytokine signaling and leukemogenesis. Therefore, our findings provide a broadly applicable approach for classifying functionally relevant genes in diverse malignancies and offer new insights into the impact of cytokine signaling on leukemia development.

Original languageEnglish (US)
Pages (from-to)773-786
Number of pages14
JournalCancer Research
Volume76
Issue number4
DOIs
StatePublished - Feb 15 2016

Fingerprint

Mutagenesis
Intercellular Signaling Peptides and Proteins
Cytokines
Aptitude
Genes
Leukemia
Beauty
Neoplasms
Cytokine Receptors
B-Lymphoid Precursor Cells
Hematologic Neoplasms
Carcinogenesis
Gene Expression
Cell Line
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Comprehensive ex vivo transposon mutagenesis identifies genes that promote growth factor independence and leukemogenesis. / Guo, Yabin; Updegraff, Barrett L.; Park, Sunho; Durakoglugil, Deniz; Cruz, Victoria H.; Maddux, Sarah; Hwang, Tae Hyun; O'Donnell-Mendell, Kathryn A.

In: Cancer Research, Vol. 76, No. 4, 15.02.2016, p. 773-786.

Research output: Contribution to journalArticle

Guo, Yabin ; Updegraff, Barrett L. ; Park, Sunho ; Durakoglugil, Deniz ; Cruz, Victoria H. ; Maddux, Sarah ; Hwang, Tae Hyun ; O'Donnell-Mendell, Kathryn A. / Comprehensive ex vivo transposon mutagenesis identifies genes that promote growth factor independence and leukemogenesis. In: Cancer Research. 2016 ; Vol. 76, No. 4. pp. 773-786.
@article{e2d2cb4f644a43de8bcb1d1ef1b7cbe7,
title = "Comprehensive ex vivo transposon mutagenesis identifies genes that promote growth factor independence and leukemogenesis",
abstract = "Aberrant signaling through cytokine receptors and their downstream signaling pathways is a major oncogenic mechanism underlying hematopoietic malignancies. To better understand how these pathways become pathologically activated and to potentially identify new drivers of hematopoietic cancers, we developed a high-throughput functional screening approach using ex vivo mutagenesis with the Sleeping Beauty transposon. We analyzed over 1,100 transposon-mutagenized pools of Ba/F3 cells, an IL3-dependent pro-B-cell line, which acquired cytokine independence and tumor-forming ability. Recurrent transposon insertions could be mapped to genes in the JAK/ STAT and MAPK pathways, confirming the ability of this strategy to identify known oncogenic components of cytokine signaling pathways. In addition, recurrent insertions were identified in a large set of genes that have been found to be mutated in leukemia or associated with survival, but were not previously linked to the JAK/STAT or MAPK pathways nor shown to functionally contribute to leukemogenesis. Forced expression of these novel genes resulted in IL3-independent growth in vitro and tumorigenesis in vivo, validating this mutagenesis-based approach for identifying new genes that promote cytokine signaling and leukemogenesis. Therefore, our findings provide a broadly applicable approach for classifying functionally relevant genes in diverse malignancies and offer new insights into the impact of cytokine signaling on leukemia development.",
author = "Yabin Guo and Updegraff, {Barrett L.} and Sunho Park and Deniz Durakoglugil and Cruz, {Victoria H.} and Sarah Maddux and Hwang, {Tae Hyun} and O'Donnell-Mendell, {Kathryn A}",
year = "2016",
month = "2",
day = "15",
doi = "10.1158/0008-5472.CAN-15-1697",
language = "English (US)",
volume = "76",
pages = "773--786",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Comprehensive ex vivo transposon mutagenesis identifies genes that promote growth factor independence and leukemogenesis

AU - Guo, Yabin

AU - Updegraff, Barrett L.

AU - Park, Sunho

AU - Durakoglugil, Deniz

AU - Cruz, Victoria H.

AU - Maddux, Sarah

AU - Hwang, Tae Hyun

AU - O'Donnell-Mendell, Kathryn A

PY - 2016/2/15

Y1 - 2016/2/15

N2 - Aberrant signaling through cytokine receptors and their downstream signaling pathways is a major oncogenic mechanism underlying hematopoietic malignancies. To better understand how these pathways become pathologically activated and to potentially identify new drivers of hematopoietic cancers, we developed a high-throughput functional screening approach using ex vivo mutagenesis with the Sleeping Beauty transposon. We analyzed over 1,100 transposon-mutagenized pools of Ba/F3 cells, an IL3-dependent pro-B-cell line, which acquired cytokine independence and tumor-forming ability. Recurrent transposon insertions could be mapped to genes in the JAK/ STAT and MAPK pathways, confirming the ability of this strategy to identify known oncogenic components of cytokine signaling pathways. In addition, recurrent insertions were identified in a large set of genes that have been found to be mutated in leukemia or associated with survival, but were not previously linked to the JAK/STAT or MAPK pathways nor shown to functionally contribute to leukemogenesis. Forced expression of these novel genes resulted in IL3-independent growth in vitro and tumorigenesis in vivo, validating this mutagenesis-based approach for identifying new genes that promote cytokine signaling and leukemogenesis. Therefore, our findings provide a broadly applicable approach for classifying functionally relevant genes in diverse malignancies and offer new insights into the impact of cytokine signaling on leukemia development.

AB - Aberrant signaling through cytokine receptors and their downstream signaling pathways is a major oncogenic mechanism underlying hematopoietic malignancies. To better understand how these pathways become pathologically activated and to potentially identify new drivers of hematopoietic cancers, we developed a high-throughput functional screening approach using ex vivo mutagenesis with the Sleeping Beauty transposon. We analyzed over 1,100 transposon-mutagenized pools of Ba/F3 cells, an IL3-dependent pro-B-cell line, which acquired cytokine independence and tumor-forming ability. Recurrent transposon insertions could be mapped to genes in the JAK/ STAT and MAPK pathways, confirming the ability of this strategy to identify known oncogenic components of cytokine signaling pathways. In addition, recurrent insertions were identified in a large set of genes that have been found to be mutated in leukemia or associated with survival, but were not previously linked to the JAK/STAT or MAPK pathways nor shown to functionally contribute to leukemogenesis. Forced expression of these novel genes resulted in IL3-independent growth in vitro and tumorigenesis in vivo, validating this mutagenesis-based approach for identifying new genes that promote cytokine signaling and leukemogenesis. Therefore, our findings provide a broadly applicable approach for classifying functionally relevant genes in diverse malignancies and offer new insights into the impact of cytokine signaling on leukemia development.

UR - http://www.scopus.com/inward/record.url?scp=84960325766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960325766&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-15-1697

DO - 10.1158/0008-5472.CAN-15-1697

M3 - Article

C2 - 26676752

AN - SCOPUS:84960325766

VL - 76

SP - 773

EP - 786

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 4

ER -